Companies starting with T

Teva

Teva

Teva Pharmaceutical Industries Limited develops, manufactures, markets, and distributes generic medicines and a portfolio of specialty medicines worldwide. It operates through two segments, Generic Medicines and Specialty Medicines. The Generic Medicines segment offers sterile products, hormones, narcotics, high-potency drugs, and cytotoxic substances in various dosage forms, including tablets, capsules, injectables, inhalants, liquids, ointments, and creams. This segment also develops, manufactures, and sells active pharmaceutical ingredients. The Specialty Medicines segment provides branded specialty medicines for use in central nervous system and respiratory indications, as well as the women’s health, oncology, and other specialty businesses. Its products in the central nervous system area comprise Copaxone for multiple sclerosis; Azilect for the treatment of Parkinson’s disease; and Nuvigil for the treatment of excessive sleepiness associated with narcolepsy and certain other disorders. This segment’s products in the respiratory market include ProAir, ProAir Respiclick, QVAR, Duoresp Spiromax, Qnasl, Braltus, Cinqair/Cinqaero, and Aerivio Spiromax for the treatment of asthma and chronic obstructive pulmonary disease, as well as Treanda/Bendeka, Granix, Trisenox, Lonquex, and Tevagrastim/Ratiograstim products in the oncology market. This segment also offers a portfolio of products in the women’s health category, which includes ParaGard, Plan B One-Step, and OTC/Rx, as well as other products. The company has collaboration arrangements with Attenukine, Procter & Gamble Company, and Regeneron Pharmaceuticals, Inc. Teva Pharmaceutical Industries Limited was founded in 1901 and is headquartered in Petach Tikva, Israel.

The Bottom Line

The Bottom Line

Stay tuned with the latest publications

Welcome to The Bottom Line (TBL). This site has been built to create a compendium of all the landmark papers which are shaping the way we manage our critically ill patients. Each paper has been summarised and critiqued using a standard template and ends with a 'bottom line' paragraph to allow a quick reminder of the key points. The papers are reviewed and cross checked by the editorial group. We take this seriously and spend time getting it accurate and as helpful for our readers as possible. If you think we have got it wrong, please let us know or use it as a discussion in the comments section. The main value of this site is the discussion of these papers and the contribution of the global FOAM community. We hope you enjoy!

The Wessex Intensive Care Society (WICS)

The Wessex Intensive Care Society (WICS)

Advancing medical practice

The Wessex Intensive Care Society (WICS) was established in the 1980's. It has rapidly developed into a society which brings together intensive care health professionals across the Wessex region.
Our aim is to advance medical practice within our intensive care units and hospitals and provide supportive training and quality education.

Our Diamond Partners

Become a partner too!

Social Media

  like us on Facebook

  follow us on Twitter

  join Discussion group

  join us on Linkedin

  newsletter sign up

  post on the blog